This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1996 Nov;14(11):1516-8.

doi: 10.1038/nbt1196-1516.

Genomic sciences and the medicine of tomorrow

J Drews¹

Affiliations

PMID: 9634812
DOI: 10.1038/nbt1196-1516

Genomic sciences and the medicine of tomorrow

J Drews. Nat Biotechnol. 1996 Nov.

. 1996 Nov;14(11):1516-8.

doi: 10.1038/nbt1196-1516.

Author

J Drews¹

Affiliation

¹ Hoffmann-La Roche, Nutley, New Jersey 07110-1199, USA.

PMID: 9634812
DOI: 10.1038/nbt1196-1516

No abstract available

PubMed Disclaimer

Similar articles

How will biotechnology fare in pharma's big plan?
[No authors listed] [No authors listed] Nat Biotechnol. 1996 Nov;14(11):1515. doi: 10.1038/nbt1196-1515. Nat Biotechnol. 1996. PMID: 9634811 No abstract available.
Unlocking the money-making potential of RNAi.
Howard K. Howard K. Nat Biotechnol. 2003 Dec;21(12):1441-6. doi: 10.1038/nbt1203-1441. Nat Biotechnol. 2003. PMID: 14647324 No abstract available.
Biotech drugs come of age; policymakers take notice.
Iglehart JK. Iglehart JK. Health Aff (Millwood). 2006 Sep-Oct;25(5):1202-3. doi: 10.1377/hlthaff.25.5.1202. Health Aff (Millwood). 2006. PMID: 16966714 No abstract available.
Drug discovery and development in the age of molecular medicine.
Vallance P, Levick M. Vallance P, et al. Clin Pharmacol Ther. 2007 Oct;82(4):363-6. doi: 10.1038/sj.clpt.6100333. Clin Pharmacol Ther. 2007. PMID: 17851574 Review.
Pharmacogenomics.
[No authors listed] [No authors listed] Nat Biotechnol. 2000 Oct;18 Suppl:IT40-2. Nat Biotechnol. 2000. PMID: 11221715 Review. No abstract available.

See all similar articles

Cited by

Drug-induced regulation of target expression.
Iskar M, Campillos M, Kuhn M, Jensen LJ, van Noort V, Bork P. Iskar M, et al. PLoS Comput Biol. 2010 Sep 9;6(9):e1000925. doi: 10.1371/journal.pcbi.1000925. PLoS Comput Biol. 2010. PMID: 20838579 Free PMC article.
Centrality of drug targets in protein networks.
Viacava Follis A. Viacava Follis A. BMC Bioinformatics. 2021 Oct 29;22(1):527. doi: 10.1186/s12859-021-04342-x. BMC Bioinformatics. 2021. PMID: 34715787 Free PMC article.
The apelin receptor inhibits the angiotensin II type 1 receptor via allosteric trans-inhibition.
Siddiquee K, Hampton J, McAnally D, May L, Smith L. Siddiquee K, et al. Br J Pharmacol. 2013 Mar;168(5):1104-17. doi: 10.1111/j.1476-5381.2012.02192.x. Br J Pharmacol. 2013. PMID: 22935142 Free PMC article.
What will be the role of pharmacogenetics in evaluating drug safety and minimising adverse effects?
Ozdemir V, Shear NH, Kalow W. Ozdemir V, et al. Drug Saf. 2001;24(2):75-85. doi: 10.2165/00002018-200124020-00001. Drug Saf. 2001. PMID: 11235820 Review.
Multi-algorithm and multi-model based drug target prediction and web server.
Liu YT, Li Y, Huang ZF, Xu ZJ, Yang Z, Chen ZX, Chen KX, Shi JY, Zhu WL. Liu YT, et al. Acta Pharmacol Sin. 2014 Mar;35(3):419-31. doi: 10.1038/aps.2013.153. Epub 2014 Feb 3. Acta Pharmacol Sin. 2014. PMID: 24487966 Free PMC article.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Other Literature Sources
- The Lens - Patent Citations Database